Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2970789344;89345;89346 chr2:178553992;178553991;178553990chr2:179418719;179418718;179418717
N2AB2806684421;84422;84423 chr2:178553992;178553991;178553990chr2:179418719;179418718;179418717
N2A2713981640;81641;81642 chr2:178553992;178553991;178553990chr2:179418719;179418718;179418717
N2B2064262149;62150;62151 chr2:178553992;178553991;178553990chr2:179418719;179418718;179418717
Novex-12076762524;62525;62526 chr2:178553992;178553991;178553990chr2:179418719;179418718;179418717
Novex-22083462725;62726;62727 chr2:178553992;178553991;178553990chr2:179418719;179418718;179418717
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Fn3-104
  • Domain position: 75
  • Structural Position: 107
  • Q(SASA): 0.1325
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/G None None 1.0 D 0.772 0.639 0.628150982837 gnomAD-4.0.0 1.59287E-06 None None None None N None 0 0 None 0 0 None 0 0 2.8582E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.9844 likely_pathogenic 0.9857 pathogenic -2.129 Highly Destabilizing 0.999 D 0.674 neutral None None None None N
R/C 0.7624 likely_pathogenic 0.7611 pathogenic -1.855 Destabilizing 1.0 D 0.837 deleterious None None None None N
R/D 0.9983 likely_pathogenic 0.9985 pathogenic -1.216 Destabilizing 1.0 D 0.819 deleterious None None None None N
R/E 0.967 likely_pathogenic 0.9699 pathogenic -0.987 Destabilizing 0.999 D 0.706 prob.neutral None None None None N
R/F 0.9894 likely_pathogenic 0.9896 pathogenic -1.209 Destabilizing 1.0 D 0.874 deleterious None None None None N
R/G 0.9857 likely_pathogenic 0.987 pathogenic -2.459 Highly Destabilizing 1.0 D 0.772 deleterious D 0.558427928 None None N
R/H 0.3698 ambiguous 0.3629 ambiguous -2.092 Highly Destabilizing 1.0 D 0.827 deleterious None None None None N
R/I 0.9659 likely_pathogenic 0.9676 pathogenic -1.15 Destabilizing 1.0 D 0.858 deleterious N 0.518927735 None None N
R/K 0.4618 ambiguous 0.5197 ambiguous -1.111 Destabilizing 0.997 D 0.685 prob.neutral N 0.501985115 None None N
R/L 0.9426 likely_pathogenic 0.9439 pathogenic -1.15 Destabilizing 1.0 D 0.772 deleterious None None None None N
R/M 0.9649 likely_pathogenic 0.968 pathogenic -1.667 Destabilizing 1.0 D 0.827 deleterious None None None None N
R/N 0.9907 likely_pathogenic 0.9918 pathogenic -1.364 Destabilizing 1.0 D 0.786 deleterious None None None None N
R/P 0.9996 likely_pathogenic 0.9997 pathogenic -1.469 Destabilizing 1.0 D 0.835 deleterious None None None None N
R/Q 0.4146 ambiguous 0.4465 ambiguous -1.166 Destabilizing 1.0 D 0.785 deleterious None None None None N
R/S 0.9898 likely_pathogenic 0.9909 pathogenic -2.196 Highly Destabilizing 1.0 D 0.762 deleterious N 0.515632372 None None N
R/T 0.9808 likely_pathogenic 0.9834 pathogenic -1.759 Destabilizing 1.0 D 0.767 deleterious N 0.510303227 None None N
R/V 0.9683 likely_pathogenic 0.97 pathogenic -1.469 Destabilizing 1.0 D 0.832 deleterious None None None None N
R/W 0.8815 likely_pathogenic 0.8791 pathogenic -0.743 Destabilizing 1.0 D 0.82 deleterious None None None None N
R/Y 0.9611 likely_pathogenic 0.9643 pathogenic -0.664 Destabilizing 1.0 D 0.863 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.